Bing

One such stock that you may want to consider dropping is CTI BioPharma Corp. (CTIC), which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year.
Yahoo Finance · 8/26/2015
Friday, Aug. 28, 2015, 72 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $47.90 to $8,027,410.00. Highlighted Stocks Traded by Insiders: Katz Samuel L, who is Director at PennantPark ...
The Street · 1 day ago
The stock is up nearly 18% in the last three trading sessions but ... Singer, EVP, Global Medical Affairs at CTI BioPharma (NASDAQ:CTIC) sold 15,000 shares at $1.58. The total value of the transaction was $23,718.
Seeking Alpha · 1 day ago
MannKind DTC Campaign
More from Bing News
CTI BioPharma Corp (CTIC) was one of the Russell 2000's biggest losers for Wednesday August 26 as the stock slid 5.63% to $1.51, a loss of $-0.09 per share. Starting at an opening price of $1.69 a share, the stock traded between $1.50 and $1.69 over the ...
Equities · 8/27/2015
Cell Therapeutics (NASDAQ:CTIC) is one of today's best performing low-priced stocks, up 5.6% to $1.70 on 2.3x average daily volume. Thus far today, Cell Therapeutics has traded 2.3 million shares, vs. average volume of 1.0 million shares per day.
Financial News Network Online · ByAdrienne Chilton · 8/21/2015
Shares of CTI BioPharma Corp. (NASDAQ:CTIC) slipped more than 10% in trade today after the company issued a press release yesterday, in which it announced it will put up its Series 21 Preferred Stock in an underwritten public offering. The company is ...
bidnessetc.com · 11/7/2014
This free program will calculate the probabilities of CTI BioPharma Corp. (CTIC) stock chart Watch the video to learn about the probability of CTI BioPharma Corp. (CTIC) Chart Signal as of Aug 31, 2015
Hot Stocked · 6/11/2015
The CTIC programs give information promoting agricultural practices ... “We now have the fifth generation coming up,” said Maring. The Marings stock includes approximately 47 head of cattle. In 1988, they open …
southernminn.com · 8/24/2015
Maring farm
CTI BioPharma Corp (NASDAQ:CTIC)‘s stock had its “buy” rating reiterated by analysts at Roth Capital in a report released on Friday, MarketBeat.Com reports. They currently have a $4.50 price objective on the biopharmaceutical company’s stock.
wkrb13.com · 8/16/2015
CTI BioPharma Corp. (CTIC - Snapshot Report) was a big mover last session, as the company saw its shares rise nearly 12% on the day. The upside came after the company released data from a Phase 3 registration-directed trial that examined pacritinib to ...
ZACKS · 6/2/2015